Incorporating lag time to benefit into prevention decisions for older adults

JAMA

Volumn 310, Issue 24, 2013, Pages 2609-2610

  Lee, Sei J ^a   Leipzig, Rosanne M ^b   Walter, Louise C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; GERIATRIC CARE; HEALTH CARE; HUMAN; LAG TIME TO BENEFIT; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDICARE; MORTALITY; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY;

EID: 84890914711     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.282612     Document Type: Short Survey

References (8)

1. Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166(6):605-609.
2. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182-192.
3. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750-2756.
4. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
5. Wei R, Curtin LR, Arias E, Anderson RN. U.S. decennial life tables for 1999-2001: methodology of the United States Life Tables. Natl Vital Stat Rep. 2008;57(4):1-9.
6. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013;346:e8441.
7. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006;295(7):801-808.
8. Patel A, MacMahon S, Chalmers J, et al ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370(9590):829-840.